Gotham Therapeutics Company
Gotham Therapeutics is discovering a novel drug class targeting the epitranscriptomics machinery.The company offers treatment options for patients suffering from cancers, auto-immune and neurodegenerative diseases.
Founded Date:
2017
Industry:
RNA & Oligonucleotide Medicines
Headquarters:
New York, New York, United States
Funding Status:
Private